The discovery of Helicobacter pyroli: a cause of peptic ulcer disease

For most of the twentieth century, peptic ulcers were attributed to stress, personality traits, excess acid, and lifestyle factors. Medical textbooks reinforced this view, and treatment strategies followed accordingly. Acid suppression, dietary changes, and even surgery were considered rational responses to a disease thought to arise from the stomach’s own chemistry and the patient’s habits.When Barry Marshall and Robin Warren proposed that a bacterium, later named Helicobacter pylori, was the primary cause of peptic ulcer disease, their hypothesis fell well outside mainstream thinking.

The stomach was assumed to be sterile, and infection was considered implausible. Their work was dismissed, ridiculed, and marginalized for years. Only after persistent evidence, clinical trials, and dramatic demonstrations did the medical community begin to accept that ulcers were, in most cases, an infectious disease. Once accepted, treatment was transformed from lifelong acid suppression to short courses of antibiotics, curing a condition once considered chronic and relapsing. The lesson was not merely that a bacterium had been overlooked. The deeper lesson was that entrenched frameworks can blind even well-intentioned experts to alternative explanations.

Ulcerative colitis today occupies a similar conceptual space to ulcers before H. pylori. It is widely described as an autoimmune or immune-mediated disease with a strong genetic component and poorly defined environmental triggers. This framing has guided decades of research and has produced therapies aimed at suppressing or modulating the immune system. Yet this model leaves profound questions unanswered.
‍
Why does the disease appear suddenly in previously healthy individuals? Why does it follow a relapsing and remitting course? Why is its incidence rising rapidly in regions undergoing industrialization? Why does immune suppression treat symptoms without addressing an identifiable root cause? These unanswered questions suggest that the dominant paradigm may be incomplete. History suggests that when explanations grow increasingly complex yet remain unsatisfying, foundational assumptions deserve reexamination.

Scientific progress does not stall because of bad intentions. It stalls because dominant ideas become self-reinforcing. Research funding, journal priorities, and career incentives often reward refinement of existing models rather than challenges to them. Hypotheses that fall outside accepted frameworks struggle to gain traction, regardless of their plausibility.

The H. pylori story demonstrates how long this process can delay meaningful breakthroughs. Patients suffered needlessly while a curable cause remained unrecognized. That delay was not caused by a lack of intelligence or effort, but by overconfidence in a prevailing narrative.Ulcerative colitis may be following a similar trajectory. The disease is treated as chronic and incurable, managed rather than resolved. This stance may reflect current limits of knowledge rather than biological reality.

Disruptions, environmental toxins, dietary components, or currently unknown mechanisms deserve rigorous exploration, even when they challenge orthodoxy. The immune system may be reacting appropriately to an unrecognized trigger rather than malfunctioning spontaneously. If so, suppressing immunity treats the downstream effects while leaving the initiating cause untouched. This possibility mirrors peptic ulcer disease, where acid was real, inflammation was real, but neither was the primary cause.

Progress in medicine has often depended on individuals willing to question what “everyone knows.” Ulcerative colitis causes immense physical suffering, psychological burden, and loss of quality of life. Accepting the current understanding as final risks repeating past mistakes.
‍
The story of Helicobacter pylori stands as a reminder that today’s fringe idea can become tomorrow’s foundational truth. Openness to new hypotheses is not a rejection of science; it is science at its best. If we truly aim to relieve the burden of ulcerative colitis, curiosity and skepticism toward our own assumptions may prove as valuable as any new drug.
Medical history suggests that cures emerge not only from better tools, but from better questions.